Presatovir

DRUG4 trials

Sponsors

Gilead Sciences

Conditions

Respiratory Syncytial VirusRespiratory Syncytial Virus (RSV)Respiratory Syncytial Virus Infection

Phase 2

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

CompletedNCT02135614

Gilead SciencesRespiratory Syncytial Virus Infection

Start: 2014-06-09End: 2017-04-12Updated: 2018-09-24

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

CompletedNCT02254408

Gilead SciencesRespiratory Syncytial Virus

Start: 2015-01-23End: 2017-07-14Updated: 2018-08-06

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

CompletedNCT02254421

Gilead SciencesRespiratory Syncytial Virus Infection

Start: 2015-01-31End: 2017-04-17Updated: 2018-09-24

Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection

CompletedNCT02534350

Gilead SciencesRespiratory Syncytial Virus (RSV)

Start: 2015-12-31End: 2017-09-27Updated: 2018-11-28

Related Papers

A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant.

2023-02-0724 citations

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

Clinical Infectious Diseases2019-12-0369 citations

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract

Clinical Infectious Diseases2019-11-2871 citations